Current trends in the development of anticoagulant and antithrombotic drugs-Reference-Cited by-同舟云学术

Current trends in the development of anticoagulant and antithrombotic drugs

Published:1994-05 Issue:3 Volume:78 Page:713-731
ISSN:0025-7125
Container-title:Medical Clinics of North America
language:en
Short-container-title:Medical Clinics of North America

Author:

Fareed Jawed,Hoppensteadt Debra,Walenga Jeanine M.,Bick Rodger L.

Publisher

Elsevier BV

Subject

General Medicine

Reference64 articles.

1. Tissue factor pathway inhibitor;Abildgaard;Rec Adv Blood Coag,1993

2. Prevention of thrombosis with warfarin or acetylsalicylic acid related to the risk of hemorrhage;Andersen;Tidsskrift For Den Narske Laegeforening,1992

3. Venous thromboembolism: Epidemiology, diagnosis, prevention;Becher;J Gen Int Med,1986

4. Frequency of thromboembolic complications;Bergqvist,1982

5. Thromboprophylaxis in patients with hip fractures: A prospective randomized, comparative study between Org 10172 and dex-tran 70;Bergqvist;Surgery,1991

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Volumenersatz mit kolloidalen Plasmaersatzmitteln;Komplikationen und Gefahren in der Anästhesie;2003

2. Bivalirudin: A Direct Thrombin Inhibitor for Percutaneous Transluminal Coronary Angioplasty;Pharmacotherapy;2002-08

3. In Vitro and in Vivo Properties of Bicyclic Lactam Inhibitors;Thrombosis Research;2000-11

4. Laboratory Monitoring of Pentasaccharide in a Dog Model of Hemodialysis;Thrombosis Research;1999-10

5. Evaluation of the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) with the factor Xa inhibitor 1,5-dansyl-L-glutamyl-L-glycyl-L-arginine chloromethylketone (GGACK) as anticoagulants for critical care clinical chemistry specimens;Clinica Chimica Acta;1999-02